Nomura Holdings’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Nomura Holdings’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,000	Closed	-$178K	–	1491
2019 Q2	$178K	Buy	+30,000	New	+$159K	﹤0.01%	1038

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's DPLO Position: Q3 2019 in Review

Nomura Holdings sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2019, closing a stake of 30,000 shares — an estimated $178K sold.

Nomura Holdings first reported a position in DPLO in Q2 2019 and held it in 1 quarter. The position peaked at $178K in Q2 2019. 137 funds tracked by Wall St. Rank hold DPLO as of Q3 2019.

Nomura Holdings reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2019 after selling out during the quarter.
Nomura Holdings sold 30,000 DIPLOMAT PHARMACY, INC. shares in Q3 2019, an estimated $178K.
Nomura Holdings first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2019 and held it in 1 quarter.
Nomura Holdings's DIPLOMAT PHARMACY, INC. position peaked at $178K in Q2 2019.
137 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2019.

Based on Nomura Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.